Chemistry Central Blog

EMBL-EBI launches OA drug discovery database

The European Molecular Biology Laboratory's European Bioinformatics Institute (EMBL-EBI) this week announced the launch of an online database - ChEMBLdb - containing information on the properties and activities of drugs and drug-like small molecules and their targets.

The database contains information on over half a million compounds.  The number of small molecules covered is over 520,000, with over 2.4 million records of their effects on biological systems.  The data includes information about how small molecules bind to their targets, how these compounds affect cells and organisms, and information on the molecules' absorption, distribution, metabolism, excretion and toxicity.

Dr John Overington, leader of the ChEMBL team at EMBL-EBI, commented that large and small pharmaceutical companies and academic institutions will all benefit from free access to the data, in their development of innovative drug therapies.

More details are available in the press release.

Posted by Jan Kuras at 15:07    Comments (0)